SFX by Ex Libris Inc.

Title:	Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
Source:	Nature Medicine [1078-8956] Su, Enming yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Lopez-Atalaya, J. "Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity." Journal of Cerebral Blood Flow and Metabolism 28.6 (2008): 1212-1221.
description	2.	Capdeville, R. "Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug." Nature reviews. Drug discovery 1.7 (2002): 493-502.
description	3.	Pekny M, M. "Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice." GLIA 22.4 (1998): 390-400.
description	4.	Wågsäter, D. "Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression." Atherosclerosis 202.2 (2008): 415-23.
description	5.	Rieckmann, P. "Imatinib buys time for brain after stroke." Nature medicine 14.7 (2008): 712-713.
description	6.	Mazitschek, R. "Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases." Current opinion in chemical biology 8.4 (2004): 432-41.
description	7.	Peek, R r. "Prevention of colorectal cancer through the use of COX-2 selective inhibitors." Cancer chemotherapy and pharmacology 54.1 (2004): -6.
description	8.	Sozener, Cemal B. "Impact of regional pre‐hospital emergency medical services in treatment of patients with acute ischemic stroke." Annals of the New York Academy of Sciences 12681.1 (2012): 51-56.
description	9.	Druker, Brian J. "Perspectives on the development of imatinib and the future of cancer research." Nature Medicine 15.10 (2009): 1149-52.
description	10.	Tang, Z. "Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3{beta} phosphorylation." The Journal of experimental medicine 207.4 (2010): 867-880.
description	11.	Costa FF, Fabricio F. "Concise review: cancer/testis antigens, stem cells, and cancer." Stem cells 25.3 (2007): 707-11.
description	12.	Sawyers, Charles L L. "Rational therapeutic intervention in cancer: kinases as drug targets." Current opinion in genetics & development 12.1 (2002): 111-5.
description	13.	Tan, Shin Y. "Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice." Journal of Pharmacy and Pharmacology 63.7 (2011): 918-925.
description	14.	Pekny, M. "Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin." The Journal of cell biology 145.3 (1999): 503-14.
description	15.	Steenport, M. "Matrix Metalloproteinase (MMP)-1 and MMP-3 Induce Macrophage MMP-9: Evidence for the Role of TNF-{alpha} and Cyclooxygenase-2." The journal of immunology 183.12 (2009): 8119-8127.
description	16.	Jonsson, Andrew D M. "Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction." Gastroenterology 133.1 (2007): 80-90.
description	17.	Lang, Philipp A. "Aggravation of viral hepatitis by platelet-derived serotonin." Nature Medicine 14.7: 756-761.
description	18.	Li, Xuri R. "Novel PDGF family members: PDGF-C and PDGF-D." Cytokine & growth factor reviews 14.2 (2003): 91-98.
description	19.	HAVERSEN, L. "Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages." Atherosclerosis 202.2 (2008): 382-393.
description	20.	Smith, Q R R. "Cerebrovascular permeability coefficients to sodium, potassium, and chloride." Journal of neurochemistry 46.6 (1986): 1732-42.